Molecular Genetic Diagnosis of a Bethlem Myopathy Family with an Autosomal-Dominant COL6A1 Mutation, as Evidenced by Exome Sequencing
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background We describe herein the application of whole exome sequencing (WES) for themolecular genetic diagnosis of a large Korean family with dominantly inherited myopathy. Case Report Te afected individuals presented with slowly progressive proximal weakness and ankle contracture. Tey were initially diagnosed with limb-girdle muscular dystrophy (LGMD) based on clinical and pathologic features. However, WES and subsequent capillary sequencing identifed a pathogenic splicing-site mutation (c.1056+1G>A) in COL6A1,which was previously reported to be an underlying cause of Bethlem myopathy. Afer identifcation of the genetic cause of the disease, careful neurologic examination revealed subtlecontracture of the interphalangeal joint in the afected members, which is a characteristicsign of Bethlem myopathy. Terefore, we revised the original diagnosis from LGMD to Bethlem myopathy. Conclusions Tis is the frst report of identifcation of COL6A1-mediated Bethlem myopathyin Korea, and indicates the utility of WES for the diagnosis of muscular dystrophy.
Abstract
Background We describe herein the application of whole exome sequencing (WES) for themolecular genetic diagnosis of a large Korean family with dominantly inherited myopathy. Case Report Te afected individuals presented with slowly progressive proximal weakness and ankle contracture. Tey were initially diagnosed with limb-girdle muscular dystrophy (LGMD) based on clinical and pathologic features. However, WES and subsequent capillary sequencing identifed a pathogenic splicing-site mutation (c.1056+1G>A) in COL6A1,which was previously reported to be an underlying cause of Bethlem myopathy. Afer identifcation of the genetic cause of the disease, careful neurologic examination revealed subtlecontracture of the interphalangeal joint in the afected members, which is a characteristicsign of Bethlem myopathy. Terefore, we revised the original diagnosis from LGMD to Bethlem myopathy. Conclusions Tis is the frst report of identifcation of COL6A1-mediated Bethlem myopathyin Korea, and indicates the utility of WES for the diagnosis of muscular dystrophy.
참고문헌 (17)
- Norwood F, "EFNS Guideline Task Force. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies", Eur J Neurol, 14, pp.1305~1312 (2007)
- Bushby K, "Diagnosis and management of the limb girdle muscular dystrophies", Pract Neurol, 9, pp.314~323 (2009)
- Ku CS, "Revisiting Mendelian disorders through exome sequencing", Hum Genet, 129, pp.351~370 (2011)
- Bamshad MJ, "Exome sequencing as a tool for Mendelian disease gene discovery", Nat Rev Genet, 12, pp.745~755 (2011)
- Davidson AE, "Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies", Brain, 136, pp.508~521 (2013)
- Klar J, "Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing", Hum Mutat, 34, pp.572~577 (2013)
- Ronchi D, "Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability", Am J Hum Genet, 92, pp.293~300 (2013)
- Weterman MA, "Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy", Brain, 136, pp.282~293 (2013)
- Choi BO, "Exome-sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease", Hum Mutat, 33, pp.1610~1615 (2012)
- Pan TC, "New molecular mechanism for Ullrich congenital muscular dystrophy:a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype", Am J Hum Genet, 73, pp.355~369 (2003)
- Lucioli S, "Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy", Neurology, 64, pp.1931~1937 (2005)
- Baker NL, "Molecular consequences of dominant Bethlem myopathy collagen VI mutations", Ann Neurol, 62, pp.390~405 (2007)
- Lamandé SR, "Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion", J Biol Chem, 274, pp.21817~21822 (1999)
- Lampe AK, "Collagen VI related muscle disorders", J Med Genet, 42, pp.673~685 (2005)
- Scacheri PC, "Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype", Neurology, 58, pp.593~602 (2002)
- Merlini L, "Bethlem myopathy:early-onset benign autosomal dominant myopathy with contractures. Description of two new families", Neuromuscul Disord, 4, pp.503~511 (1994)
- Metzker ML, "Sequencing technologies - the next generation", Nat Rev Genet, 11, pp.31~46 (2010)
